Multiple sclerosis prevalence in England doubles due to better diagnosis

	Multiple Sclerosis
	The latest multiple sclerosis news from News Medical

	Multiple sclerosis prevalence in England doubles due to better diagnosis Multiple sclerosis (MS) has more than doubled in recorded prevalence in England from 2000 to 2020, increasing by 6% per year, largely due to improved diagnosis and longer life expectancy, finds a new study by University College London (UCL) and Imperial College London researchers.

	Identifying the cellular origin of MS-related neuroinflammation Signals from the gut have been linked to autoimmune inflammation, but fundamental cellular processes remain poorly understood.

			Anti-aging drug combination causes brain damage in mice A two-drug combination frequently used in anti-aging research causes brain damage in mice, University of Connecticut researchers report in the March 16 issue of PNAS.

			Cancer-fighting antibodies may trigger autoimmune brain disorders Consider two seemingly unrelated medical puzzles. First: Every day, our bodies produce hundreds of billions of new cells, many of which are mutated.

	Largest review finds no mental health benefits of medicinal cannabis A landmark Lancet Psychiatry paper published today – the largest-ever review of the safety and efficacy of cannabinoids across a range of mental health conditions – found no evidence that medicinal cannabis is effective in treating anxiety, depression or post-traumatic stress disorder (PTSD).

	Gut immune responses found to trigger brain inflammation in MS Multiple sclerosis (MS) is a debilitating neurological disorder caused by malfunctioning immune responses that target the brain and spinal cord of the central nervous system (CNS).

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026